Agree. His presence on the board is of note and he gives weight to the science. Now need the marketing dept to sell more treatment plans.
interestingly CoVid has had a significant impact on Varian and their oncology treatments - OSL are not alone in being set back by the impact of CoVid on hospitals
Ann: Prof. Ricky Sharma appointed to the Board of OncoSil, page-6
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.2¢ |
Change
0.002(15.0%) |
Mkt cap ! $43.51M | |||
| Open | High | Low | Value | Volume |
| 1.1¢ | 1.2¢ | 1.1¢ | $123.5K | 11.18M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 3285939 | 1.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.2¢ | 7434758 | 11 |
View Market Depth
| Last trade - 14.43pm 15/08/2024 (20 minute delay) ? |
| OSL (ASX) Chart |